Cumberland Pharmaceuticals Inc. is a Nashville-based specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription pharmaceuticals. Its FDA-approved portfolio includes Acetadote (acetylcysteine injection), Caldolor (ibuprofen injection), Kristalose (lactulose), Sancuso (granisetron transdermal), Vaprisol (conivaptan injection), Vibativ (telavancin injection), and Talicia (omeprazole/amoxicillin/rifabutin). The company targets hospital acute care, gastroenterology, and oncology markets, and also has clinical-stage programs for ifetroban in Duchenne muscular dystrophy cardiomyopathy, systemic sclerosis, and idiopathic pulmonary fibrosis.
expected 2026-11-27
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001087294-26-000020 | EDGAR | 62K words |
| 2025-03-07 | 2024-12-31 | 0001628280-25-011366 | EDGAR | 60K words |
| 2024-03-13 | 2023-12-31 | 0001628280-24-010725 | EDGAR | 61K words |
| 2023-03-13 | 2022-12-31 | 0001628280-23-007727 | EDGAR | 67K words |
| 2022-03-11 | 2021-12-31 | 0001628280-22-005942 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001628280-21-004654 | EDGAR | — |
| 2020-03-20 | 2019-12-31 | 0001628280-20-003880 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001628280-19-002785 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001628280-18-003034 | EDGAR | — |
| 2017-03-13 | 2016-12-31 | 0001628280-17-002485 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001087294-26-000062 | EDGAR | 24K words |
| 2025-11-07 | 2025-09-30 | 0001087294-25-000020 | EDGAR | 17K words |
| 2025-08-08 | 2025-06-30 | 0001628280-25-039326 | EDGAR | 16K words |
| 2025-05-09 | 2025-03-31 | 0001628280-25-024342 | EDGAR | 14K words |
| 2024-11-08 | 2024-09-30 | 0001628280-24-046730 | EDGAR | 17K words |
| 2024-08-09 | 2024-06-30 | 0001628280-24-036529 | EDGAR | 16K words |
| 2024-05-10 | 2024-03-31 | 0001628280-24-022658 | EDGAR | 15K words |
| 2023-11-13 | 2023-09-30 | 0001628280-23-038418 | EDGAR | 20K words |
| 2023-08-11 | 2023-06-30 | 0001628280-23-029112 | EDGAR | 21K words |
| 2023-05-12 | 2023-03-31 | 0001628280-23-017951 | EDGAR | 18K words |
| 2022-11-14 | 2022-09-30 | 0001628280-22-029906 | EDGAR | 21K words |
| 2022-08-12 | 2022-06-30 | 0001628280-22-022735 | EDGAR | 20K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-28 | 0001087294-26-000064 | EDGAR | 1K words |
| 2026-08-04 | 0001087294-26-000058 | EDGAR | 5K words |
| 2026-07-13 | 0001087294-26-000055 | EDGAR | 1K words |
| 2026-03-03 | 0001087294-26-000015 | EDGAR | 6K words |
| 2026-02-04 | 0001087294-26-000011 | EDGAR | 1K words |
| 2025-11-24 | 0001087294-25-000023 | EDGAR | 1K words |
| 2025-11-04 | 0001087294-25-000017 | EDGAR | 6K words |
| 2025-10-21 | 0001087294-25-000012 | EDGAR | 1K words |
| 2025-08-05 | 0001628280-25-037923 | EDGAR | 5K words |
| 2025-05-06 | 0001628280-25-022753 | EDGAR | 4K words |
337 total filings indexed. 305 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001087294 |
| Ticker | CPIX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | TN |
| Headquarters | Nashville, Tennessee |
| Website | https://www.cumberlandpharma.com |
| Listed | 2009-08-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CPIX (~200 tokens, structured JSON with cryptographic provenance)